BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 283 filers reported holding BLUEBIRD BIO INC in Q4 2019. The put-call ratio across all filers is 0.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $9,000 | 0.0% | 173 | +14.6% | 0.00% | 0.0% |
| Q2 2020 | $9,000 | -50.0% | 151 | -62.2% | 0.00% | -75.0% |
| Q1 2020 | $18,000 | -37.9% | 399 | +20.9% | 0.00% | -50.0% |
| Q4 2019 | $29,000 | +7.4% | 330 | +10.7% | 0.01% | 0.0% |
| Q3 2019 | $27,000 | -12.9% | 298 | +20.6% | 0.01% | -27.3% |
| Q2 2019 | $31,000 | – | 247 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 82,500 | $5,090,000 | 4.20% |
| RTW INVESTMENTS, LP | 122,576 | $7,563,000 | 2.85% |
| Eventide Asset Management | 587,677 | $36,260,000 | 2.36% |
| First Light Asset Management, LLC | 71,246 | $4,396,000 | 1.93% |
| ARK Investment Management | 75,645 | $4,667,000 | 1.70% |
| Taylor Wealth Management Partners | 39,118 | $2,414,000 | 1.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 302,027 | $18,635,000 | 0.77% |
| ARMISTICE CAPITAL, LLC | 40,000 | $2,468,000 | 0.58% |
| Artal Group S.A. | 422,536 | $26,070,000 | 0.58% |
| Baillie Gifford | 5,164,467 | $318,647,000 | 0.52% |